1 recruiting, 1 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Withdrawn 1 |
Follow Aspirin: new trials by email Literature Review of Aspirin trials Research Report on Aspirin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II Aspirin 81Mg Ec Tab twice daily for 7 days, Aspirin 40Mg Chew Tab twice daily for 7 days, Aspirin 162 mg EC Tab once daily for 7 days - Platelet Aggregation, Type 2 Diabetes | Phase 1 | Recruiting | Montreal Heart Institute | 30 | 2023-06-13 | 2025-12-03 |
| Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack aspirin versus clopidogrel - Transient Ischemic Attack, Stroke | Phase 1 | Withdrawn | University of California, San Diego | 2006-08-01 | 2019-08-02 |
Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Ischemic Attack, Transient (1) · Stroke (1)
Brain Diseases (1) · Brain Ischemia (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nervous System Diseases (1) · Nutritional and Metabolic Diseases (1) · Vascular Diseases (1)
Aspirin (1) · Mastication (1)
Montreal Heart Institute (1) · University of California, San Diego (1)
Canada (1) · United States (1)
Guillaume Marquis Gravel, MD, MSc (1) · Matt B Jensen, MD (1)